8-K - Amphastar Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Regulation Fd

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. Entry into Material Definitive Agreement and Amendment of a Material Definitive Agreement. Material Definitive Agreement. On January 6, 2026, Amphastar Ph

Material Agreement

$2.0M$14.0M$75.0M$7.5M

7.01

of this Current Report on Form 8-K is not deemed to be “filed” for the purpose of Section 18 of the Securities Act of 1933, or the Securities Act of 1934, excep

Regulation Fd

9.01

. Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release, dated January 12, 2026 of Amphastar Pharmaceuticals, Inc. 104 Cov

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1